mirror of
https://github.com/OpenBB-finance/OpenBB.git
synced 2026-11-03 07:51:49 +00:00
4ad995fdd0
* add first iteration of content for Terminal Pro * Update index.md * Update dashboards.md * Update folders.md * Update grouping.md * Update report.md * Update templates.md * Update quick-start.md * Update index.md * Update index.md * Update home.md * Update news.md * Update index.md * Update index.md * Update index.md * Update data-provider.md * Update chat-with-widget.md * Update data-manipulation.md * Update forecasting.md * fix: images self closing tags * fix: only pro visitors can see pro * inter font * improve SEO content and restructuring * add new package for toggle on tutorials * move folder around * improve main page of each prod * small updates and improvements * fix logo above * small improvement in headtitle for portfolio funcs * fix typos from OpenAI's GPT-4 * fix _category_ json * remove generic SEO words * add script that generates SEO for documentation * add missing file * remove sdk warning message * fix links for andrew --------- Co-authored-by: jose-donato <zmcdonato@gmail.com> Co-authored-by: jose-donato <43375532+jose-donato@users.noreply.github.com> Co-authored-by: andrewkenreich <andrew.kenreich@gmail.com>
12 KiB
Vendored
12 KiB
Vendored
title, description, keywords
| title | description | keywords | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| lit | This Docusaurus page provides access to the latest insider trading information. With the lit function, users can limit the number of data rows to display and view pertinent details like trade date, ticker, company name, insider name, title, trade type, price, qty, owned, diff own and value. |
|
import HeadTitle from '@site/src/components/General/HeadTitle.tsx';
Print latest insider trading. [Source: OpenInsider]
Usage
lit [-l LIMIT]
Parameters
| Name | Description | Default | Optional | Choices |
|---|---|---|---|---|
| limit | Limit of datarows to display | 10 | True | None |
Examples
2022 Feb 16, 07:58 (🦋) /stocks/ins/ $ lit
Insider Data
┏━━━━┳━━━━━━━━━━━━━┳━━━━━━━━━━━━┳━━━━━━━━┳━━━━━━━━━━━━━━━━━━━┳━━━━━━━━━━━━━━━━━━━━━━┳━━━━━━━━━━━━┳━━━━━━━━━━━━━━┳━━━━━━━━┳━━━━━━━━━━━━┳━━━━━━━━━━━┳━━━━━━━━━━┳━━━━━━━━━━━━━━┓
┃ X ┃ Filing Date ┃ Trade Date ┃ Ticker ┃ Company Name ┃ Insider Name ┃ Title ┃ Trade Type ┃ Price ┃ Qty ┃ Owned ┃ Diff Own ┃ Value ┃
┡━━━━╇━━━━━━━━━━━━━╇━━━━━━━━━━━━╇━━━━━━━━╇━━━━━━━━━━━━━━━━━━━╇━━━━━━━━━━━━━━━━━━━━━━╇━━━━━━━━━━━━╇━━━━━━━━━━━━━━╇━━━━━━━━╇━━━━━━━━━━━━╇━━━━━━━━━━━╇━━━━━━━━━━╇━━━━━━━━━━━━━━┩
│ M │ 2022-02-16 │ 2022-02-09 │ ZIVO │ Zivo Bioscience, │ Maggiore Christopher │ Dir, 10% │ P - Purchase │ $3.72 │ +91,334 │ 803,105 │ +13% │ +$340,098 │
│ │ 06:02:09 │ │ │ Inc. │ D. │ │ │ │ │ │ │ │
├────┼─────────────┼────────────┼────────┼───────────────────┼──────────────────────┼────────────┼──────────────┼────────┼────────────┼───────────┼──────────┼──────────────┤
│ M │ 2022-02-15 │ 2022-02-11 │ RSVR │ Reservoir Media, │ Richmond Hill │ May be │ P - Purchase │ $6.75 │ +136,364 │ 136,364 │ New │ +$920,717 │
│ │ 21:57:01 │ │ │ Inc. │ Investments, LLC │ deemed a │ │ │ │ │ │ │
│ │ │ │ │ │ │ 10% owner │ │ │ │ │ │ │
├────┼─────────────┼────────────┼────────┼───────────────────┼──────────────────────┼────────────┼──────────────┼────────┼────────────┼───────────┼──────────┼──────────────┤
│ M │ 2022-02-15 │ 2022-02-11 │ RSVR │ Reservoir Media, │ Richmond Hill │ May be │ P - Purchase │ $6.75 │ +58,441 │ 58,441 │ New │ +$394,588 │
│ │ 21:56:17 │ │ │ Inc. │ Capital Partners, LP │ deemed a │ │ │ │ │ │ │
│ │ │ │ │ │ │ 10% owner │ │ │ │ │ │ │
├────┼─────────────┼────────────┼────────┼───────────────────┼──────────────────────┼────────────┼──────────────┼────────┼────────────┼───────────┼──────────┼──────────────┤
│ M │ 2022-02-15 │ 2022-02-11 │ KNTE │ Kinnate Biopharma │ Gordon Carl L │ Dir │ P - Purchase │ $10.17 │ +195,700 │ 4,043,629 │ +5% │ +$1,989,446 │
│ │ 21:51:12 │ │ │ Inc. │ │ │ │ │ │ │ │ │
├────┼─────────────┼────────────┼────────┼───────────────────┼──────────────────────┼────────────┼──────────────┼────────┼────────────┼───────────┼──────────┼──────────────┤
│ M │ 2022-02-15 │ 2022-02-11 │ KNTE │ Kinnate Biopharma │ Orbimed Advisors LLC │ Dir │ P - Purchase │ $10.17 │ +195,700 │ 4,043,629 │ +5% │ +$1,989,446 │
│ │ 21:42:44 │ │ │ Inc. │ │ │ │ │ │ │ │ │
├────┼─────────────┼────────────┼────────┼───────────────────┼──────────────────────┼────────────┼──────────────┼────────┼────────────┼───────────┼──────────┼──────────────┤
│ DM │ 2022-02-15 │ 2022-02-14 │ RSVR │ Reservoir Media, │ Cook Stephen M. │ Dir │ P - Purchase │ $7.29 │ +41,510 │ 1,057,171 │ +4% │ +$302,565 │
│ │ 21:32:18 │ │ │ Inc. │ │ │ │ │ │ │ │ │
├────┼─────────────┼────────────┼────────┼───────────────────┼──────────────────────┼────────────┼──────────────┼────────┼────────────┼───────────┼──────────┼──────────────┤
│ D │ 2022-02-15 │ 2022-02-14 │ BVS │ Bioventus Inc. │ D'Adamio Anthony │ SVP, GC │ S - Sale+OE │ $11.99 │ -1,294 │ 18,672 │ -6% │ -$15,513 │
│ │ 21:31:03 │ │ │ │ │ │ │ │ │ │ │ │
├────┼─────────────┼────────────┼────────┼───────────────────┼──────────────────────┼────────────┼──────────────┼────────┼────────────┼───────────┼──────────┼──────────────┤
│ DM │ 2022-02-15 │ 2022-02-11 │ AREN │ Arena Group │ B. Riley Financial, │ 10% │ P - Purchase │ $8.26 │ +1,977,982 │ 5,411,514 │ +58% │ +$16,329,921 │
│ │ 21:30:53 │ │ │ Holdings, Inc. │ Inc. │ │ │ │ │ │ │ │
├────┼─────────────┼────────────┼────────┼───────────────────┼──────────────────────┼────────────┼──────────────┼────────┼────────────┼───────────┼──────────┼──────────────┤
│ D │ 2022-02-15 │ 2022-02-14 │ BVS │ Bioventus Inc. │ Anglum Gregory O. │ SVP, CFO │ S - Sale+OE │ $11.99 │ -1,294 │ 55,013 │ -2% │ -$15,518 │
│ │ 21:27:43 │ │ │ │ │ │ │ │ │ │ │ │
├────┼─────────────┼────────────┼────────┼───────────────────┼──────────────────────┼────────────┼──────────────┼────────┼────────────┼───────────┼──────────┼──────────────┤
│ D │ 2022-02-15 │ 2022-02-14 │ BVS │ Bioventus Inc. │ Nosenzo John │ Chief │ S - Sale+OE │ $11.99 │ -534 │ 43,370 │ -1% │ -$6,401 │
│ │ 21:17:44 │ │ │ │ │ Commercial │ │ │ │ │ │ │
│ │ │ │ │ │ │ Officer │ │ │ │ │ │ │
└────┴─────────────┴────────────┴────────┴───────────────────┴──────────────────────┴────────────┴──────────────┴────────┴────────────┴───────────┴──────────┴──────────────┘
D: Derivative transaction in filing (usually option exercise)
M: Multiple transactions in filing; earliest reported transaction date & weighted average transaction price